PFS
NBIX icon

Prospera Financial Services’s Neurocrine Biosciences NBIX Stock Holding History

Prospera Financial Services’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Buy
+1,429
New +$212K ﹤0.01% 1329
2026
Q1 		– Sell
-3,895
Closed -$552K – 1475
2025
Q4 		$552K Buy
3,895
+42
+1% +$6.08K 0.01% 890
2025
Q3 		$541K Buy
3,853
+18
+0.5% +$2.44K 0.01% 907
2025
Q2 		$482K Buy
3,835
+1,158
+43% +$133K 0.01% 920
2025
Q1 		$296K Buy
2,677
+86
+3% +$10.9K 0.01% 992
2024
Q4 		$354K Buy
2,591
+9
+0.3% +$1.11K 0.01% 867
2024
Q3 		$297K Sell
2,582
-24
-0.9% -$3.29K 0.01% 924
2024
Q2 		$359K Sell
2,606
-333
-11% -$45.7K 0.01% 842
2024
Q1 		$405K Buy
2,939
+100
+4% +$13.7K 0.01% 776
2023
Q4 		$374K Sell
2,839
-85
-3% -$9.78K 0.01% 754
2023
Q3 		$329K Sell
2,924
-73
-2% -$7.69K 0.01% 769
2023
Q2 		$283K Buy
+2,997
New +$293K 0.01% 823
2022
Q2 		– Sell
-496
Closed -$46K – 2248
2022
Q1 		$46K Buy
+496
New +$42K ﹤0.01% 1413
2021
Q3 		– Sell
-12,679
Closed -$1.23M – 834
2021
Q2 		$1.23M Buy
+12,679
New +$1.22M 0.06% 336
2020
Q4 		– Sell
-10
Closed -$1K – 1245
2020
Q3 		$1K Buy
+10
New +$1.16K ﹤0.01% 1557

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Prospera Financial Services's NBIX Position: Q2 2026 in Review

Prospera Financial Services opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 1,429 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #1329 among its holdings. This is a return to the name: Prospera Financial Services previously reported a position in NBIX as recently as Q4 2025.

Prospera Financial Services first reported a position in NBIX in Q3 2020 and has held it in 15 quarters since. The position peaked at $1.23M in Q2 2021. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Prospera Financial Services held 1,429 shares of Neurocrine Biosciences worth $241K as of Q2 2026.
  • Neurocrine Biosciences was a new Prospera Financial Services position in Q2 2026.
  • Neurocrine Biosciences made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1329 holding.
  • Prospera Financial Services first reported a position in Neurocrine Biosciences in Q3 2020 and has held it in 15 quarters since.
  • Prospera Financial Services's Neurocrine Biosciences position peaked at $1.23M in Q2 2021.
  • 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.